Oliver Königsbrügge

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 12

Top Topics

Atrial Fibrillation

End Stage Renal Disease

Oral Anticoagulants

Inferior Vena Cava

Top Venues

International journal of molecular sciences

Journal of thrombosis and haemostasis : JTH

Research and practice in thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Cornelia Englisch, Oliver Königsbrügge, Stephan Nopp, Florian Moik, Peter Quehenberger, Matthias Preusser, Ingrid Pabinger, Cihan Ay
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer. International journal of molecular sciences 23 (24) (2022)
Cornelia Englisch, Oliver Königsbrügge, Stephan Nopp, Florian Moik, Peter Quehenberger, Matthias Preusser, Ingrid Pabinger, Cihan Ay
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer. International journal of molecular sciences 23 (24) (2022)
Cornelia Englisch, Oliver Königsbrügge, Stephan Nopp, Florian Moik, Peter Quehenberger, Matthias Preusser, Ingrid Pabinger, Cihan Ay
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer. International journal of molecular sciences 23 (24) (2022)
Cornelia Englisch, Oliver Königsbrügge, Stephan Nopp, Florian Moik, Peter Quehenberger, Matthias Preusser, Ingrid Pabinger, Cihan Ay
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer. International journal of molecular sciences 23 (24) (2022)
Edit Porpaczy, Philipp Wohlfarth, Oliver Königsbrügge, Werner Rabitsch, Cathrin Skrabs, Philipp Staber, Nina Worel, Leonhard Müllauer, Ingrid Simonitsch-Klupp, Christoph Kornauth, Johannes Rohrbeck, Ulrich Jaeger, Ana-Iris Schiefer
Influence of TP53 Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era. Cancers 13 (22) (2021)
Oliver Königsbrügge, Hannah Meisel, Aljoscha Beyer, Sabine Schmaldienst, Renate Klauser-Braun, Matthias Lorenz, Martin Auinger, Josef Kletzmayr, Manfred Hecking, Wolfgang C Winkelmayer, Irene Lang, Ingrid Pabinger, Marcus Säemann, Cihan Ay
Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population-based prospective cohort study. Journal of thrombosis and haemostasis : JTH 19 (12) (2021)
Judit Rejtö, Oliver Königsbrügge, Ella Grilz, Stefanie Hofer, Lisa-Marie Mauracher, Cornelia Gabler, Gerhard Schuster, Clemens Feistritzer, Raute Sunder-Plaßmann, Peter Quehenberger, Johanna Gebhart, Cihan Ay, Ingrid Pabinger
Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non-severe haemophilia A. Journal of thrombosis and haemostasis : JTH 18 (5) (2020)
Stephan Nopp, Karin Janata-Schwatczek, Helmut Prosch, Ihor Shulym, Oliver Königsbrügge, Ingrid Pabinger, Cihan Ay
Pulmonary embolism during the COVID-19 pandemic: Decline in diagnostic procedures and incidence at a university hospital. Research and practice in thrombosis and haemostasis 4 (5) (2020)
Oliver Königsbrügge, Cihan Ay
Atrial fibrillation in patients with end-stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation. Research and practice in thrombosis and haemostasis 3 (4) (2019)
Ella Grilz, Christine Marosi, Oliver Königsbrügge, Julia Riedl, Florian Posch, Wolfgang Lamm, Irene M Lang, Ingrid Pabinger, Cihan Ay
Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer. Journal of thrombosis and haemostasis : JTH 17 (8) (2019)
Oliver Königsbrügge, Günter Weigel, Peter Quehenberger, Ingrid Pabinger, Cihan Ay
Plasma clot formation and clot lysis to compare effects of different anticoagulation treatments on hemostasis in patients with atrial fibrillation. Clinical and experimental medicine 18 (3) (2018)
Oliver Königsbrügge, Alexander Simon, Hans Domanovits, Ingrid Pabinger, Cihan Ay
Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry. BMC cardiovascular disorders 16 (1) (2016)